Methacrylic Acid

Methacrylic Acid

SCHEMBL4069606

C=C(C)C(=O)O.CN(C)CCOCCN(C)C

nearest known ligand 0.45

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 1/20 0.45
CHRM2 P08172 1/20 0.43
CHRM4 P08173 1/20 0.43
CHRM5 P08912 1/20 0.43
CHRM1 P11229 1/20 0.43
CHRNB2 P17787 1/20 0.43
CHRM3 P20309 1/20 0.43
CHRNA4 P43681 1/20 0.43
KDM4E B2RXH2 12/20 0.43
ALDH1A1 P00352 8/20 0.43
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA9 Q16790 1/20 0.41
TDP1 Q9NUW8 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
USP2 O75604 1/20 0.40
LMNA P02545 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Oxalic Acid SCHEMBL7529345 0.86 RAB9A (0.54) RAB9ACHRM2CHRM4CHRM5CHRM1
Acetone SCHEMBL28266443 0.84 CHRM2 (0.52) RAB9ACHRM2CHRM4CHRM5CHRM1
Methacrylic Acid SCHEMBL27816657 0.83 CHRM1 (0.50) RAB9ACHRM2CHRM4CHRM5CHRM1
Methacrylic Acid SCHEMBL11969913 0.82 THRB (0.48) CHRM2CHRM4CHRM5CHRM1CHRNB2
SCHEMBL3644189 0.82 RAB9A (0.42) RAB9ACHRM2CHRM4CHRM5CHRM1
Methacrylic Acid SCHEMBL319586 0.82 THRB (0.48) CHRM2CHRM4CHRM5CHRM1CHRNB2
SCHEMBL771008 0.80 THRB (0.61) RAB9ACHRM2CHRM4CHRM5CHRM1
SCHEMBL389440 0.80 THRB (0.61) RAB9ACHRM2CHRM4CHRM5CHRM1
Methacrylic Acid SCHEMBL28172340 0.80 CHRM2 (0.47) RAB9ACHRM2CHRM4CHRM5CHRM1
SCHEMBL19480170 0.79 CHRM2 (0.41) RAB9ACHRM2CHRM4CHRM5CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090306380-A1 Process for preparing 4-amino-2-alkylthio-5-pyrimidinecarbaldehyde UBE INDUSTRIES, LTD. (JP) 2009-12-10 US claimed
US-20090306380-A1 Process for preparing 4-amino-2-alkylthio-5-pyrimidinecarbaldehyde UBE INDUSTRIES, LTD. (JP) 2009-12-10 US disclosed
US-20090306380-A1 Process for preparing 4-amino-2-alkylthio-5-pyrimidinecarbaldehyde UBE INDUSTRIES, LTD. (JP) 2009-12-10 US disclosed
US-20090041843-A1 PHARMACEUTICAL PREPARATION HAVING EXCELLENT PHOTOSTABILITY KOWA CO., LTD. (JP) 2009-02-12 US disclosed
EP-1944029-A1 PHARMACEUTICAL PREPARATION HAVING EXCELLENT PHOTOSTABILITY Kowa Company, Ltd. (JP) 2008-07-16 EP disclosed
CN-101166713-A Process for producing 4-amino-2-alkylthio-5-pyrimidinecarbaldehyde UBE INDUSTRIES (JP) 2008-04-23 CN disclosed
WO-2006115237-A1 PROCESS FOR PRODUCING 4-AMINO-2-ALKYLTHIO-5-PYRIMIDINECARBALDEHYDE UBE INDUSTRIES, LTD. (JP) 2006-11-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090306380-A1 Process for preparing 4-amino-2-alkylthio-5-pyrimidinecarbaldehyde NUDT1, DPYD, TPMT RAB9A 4690/4885CHRM2 3934/4885CHRM4 3394/4885
US-20090041843-A1 PHARMACEUTICAL PREPARATION HAVING EXCELLENT PHOTOSTABILITY HMGCR, PCSK9, CYP4A11 RAB9A 439/4885CHRM2 3569/4885CHRM4 3128/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.